DOI: 10.36347/sjmcr.2020.v08i09.011

Pages: 846-853

Forty volunteers (comprising of four families whose members were both amalgamation of nuclear and extended) and eight COVID 19 disease confirmed positive cases unisex attending National Hospital Abuja either as in /out patients randomly participated in this pilot study; The sole objective was to determine the effectiveness of Joseleen herbal lipids mixture as both therapeutic and prophylactic agent against COVID 19 disease. We initially proposed Joseleen Herbal Mixture as a prophylactic agent for COVID19 disease, following its high potential of protecting individuals against Coronavirus infection, as evidenced from haemagglutination inhibition assay16,17 carried out using influenza virus, a closely related virus with 80% sequence homology. Randomized assay conducted on those infected with COVID 19 disease revealed its high therapeutic potential, after administering informed consent questionnaires to volunteers. Four indicators were used to critically appraise the herbal lipids mixture. These were, Percentage overall rating of the herbal lipids Mixture by volunteers; Their prophylactic experience with the herbal mixture after staying with COVID 19 patients for a period between 20 – 60 days; Curative experience of the volunteers who were infected initially with corona virus; Side effect experience of these same group of volunteers. The outcomes showed, percentage ratings of 83.1%, 94.43%, 100% and 17% respectively. ANOVA statistic technique revealed significantly different high percentage ratings among the first three indicators (P ≤ 0.05). However, the side effect percentage rating was significantly lower than the other three indicators (P≤ 0.05). Thus, Joseleen herbal mixture is both effectively therapeutic and prophylactic against COVID 19 pandemic disease. The case fatality rate was zero % with respect to this research, using Joseleen herbal lipids mixture as COVID 19 remedy.